GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh ...

Scientists are probing woolly mammoth and Neanderthal genetic codes for new compounds as today’s drugs lose potency.

U.S. senator wants to know how the FDA will enforce drug ad regulations after letting go numerous workers from the office ...

WINNIPEG, Manitoba, May 29, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) ("Kane Biotech”, "Kane” or the "Company”) ...

The British drugmaker may have succeeded in reviving an oral antibiotic previously rejected by the FDA when it was under ...

Biotechnology has emerged as a driving force in transforming healthcare. Over the past few decades, the integration of biology with advanced technology has led to significant breakthroughs. These ...

Clinigen has entered a new phase of collaboration with Japanese drugmaker Shionogi (TYO: 4507), signing a licensing agreement ...

Despite the crucial need for new antibiotics, there has been little innovation in the past 20 years. According to a report from the Biotechnology Innovation Organization, “more than 82% of all ...

Antimicrobial resistance is a growing issue in aquaculture. Researchers discovered that combinations of bacteria from live-feed microalgae are capable of inhibiting pathogens.

While most pharma companies have exited the antibiotics area, Japanese drugmaker Shionogi has stuck with it and has just expanded its pipeline with a deal to buy US biotech Qpex Biopharma.

Tech oligarchs’ wildest visions of tomorrow amount to a modern secular theology that is both mesmerizing and, in his view, ...

GSK and Spero ended a Phase 3 trial early meeting efficacy goals in cUTIs, positioning its treatment as the first oral ...